Cme (CME) Net Income towards Common Stockholders (2009 - 2026)

Cme (CME) has reported Net Income towards Common Stockholders for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• Quarterly Net Income towards Common Stockholders rose 2.92% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.3 billion (up 14.86% YoY) and the FY2025 annual result came in at $4.0 billion, up 15.5% from the prior year.
• Net Income towards Common Stockholders slipped to $1.0 billion in Q2 2026 per CME's latest filing, from $1.2 billion in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for CME reached as high as $1.2 billion in Q4 2025 and fell as low as $630.0 million in Q4 2022.
• A 5-year average of $864.2 million and a median of $867.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slipped 27.57% — and 2025, when it surged 35.23%.
• Year by year, Net Income towards Common Stockholders stood at $630.0 million in 2022, then rose by 27.67% to $804.3 million in 2023, then gained by 7.39% to $863.7 million in 2024, then jumped by 35.23% to $1.2 billion in 2025, then declined by 10.8% to $1.0 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $1.0 billion, $1.2 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.